Status:
COMPLETED
Comparison of Mesh Nebulizer and Compressor Nebulizer With Pulmonary Function Test in Pediatric Asthma Attacks
Lead Sponsor:
Berker Okay
Conditions:
Asthma
Asthma in Children
Eligibility:
All Genders
7-15 years
Phase:
NA
Brief Summary
Asthma is a worldwide health problem and is one of the most common chronic diseases of childhood in most countries. Symptoms begin before the age of 5 years in 80% of children with asthma, but the dia...
Eligibility Criteria
Inclusion
- Asthma attack patients who need inhaler therapy (salbutamol)
- Patients aged 7-15 years and whose families gave consent for the study
Exclusion
- Patients with neuromotor impairment
- Patients with underlying chronic disease (neurological disease such as epilepsy or congenital heart disease)
- Patients with obesity or malnutrition (to equalize drug dose efficacy)
- Patients with those receiving adrenaline, budesonide or ipratropium bromide therapy
- Patients who have used a long-acting bronchodilator in the last 12 hours or a short-acting bronchodilator in the last 2 hours
- Patients with fever above 37.5°C
- Patients with a saturation value below 92% at the time of admission
- Patients with severe asthma attack
- Patients with respiratory failure
- Patients who had problems in performing the test (such as mental retardation, patient incompatibility)
- Patients with diseases involving the chest muscles and those with chronic lung diseases (such as cystic fibrosis, bronchiectasis)
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06211998
Start Date
August 1 2022
End Date
August 1 2023
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHS Haseki Training and Research Hospital
Istanbul, Sultangazi, Turkey (Türkiye), 34304